What has NICE said?
Edoxaban (Lixiana) is recommended as an option for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation who have one or more risk factors, such as:
What does this mean for me?
If you have non‑valvular atrial fibrillation and your doctor thinks that edoxaban is the right treatment, you should be able to have the treatment on the NHS.
Edoxaban should be available on the NHS within 3 months of the guidance being issued.